Publication Name	World Journal of Clinical Cases
Manuscript ID	90120
Country	China

Received	2023-11-23 15:39
Peer-Review Started	2023-11-23 15:40
To Make the First Decision
Return for Revision	2024-02-06 20:58
Revised	2024-02-19 14:20
Second Decision	2024-03-28 06:50
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2024-03-28 08:05
Articles in Press	2024-03-28 08:05
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-04-01 07:12
Publish the Manuscript Online	2024-04-11 08:04

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Letter to the Editor
Article Title	Intestinal flora: New perspective of type 2 diabetes
Manuscript Source	Unsolicited Manuscript
All Author List	Yan Liu, Jun Chang and Li-Ding Bai
Funding Agency and Grant Number
Corresponding Author	Jun Chang, MD, PhD, Researcher, NA, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, No. 88 Changling Road, Xiqing District, Tianjin 300381, China, Tianjin 300381, China. cj2020_91@163.com
Key Words	Microbial metabolites; Intestinal flora; Probiotics; Insulin resistance; Type 2 diabetes
Core Tip	With the global prevalence of diabetes continuing to rise, China faces a particularly high burden, with diabetes and its complications affecting up to 10% of the population. Type 2 diabetes mellitus (T2DM) constitutes over 90% of these cases. While insulin remains the primary treatment for T2DM, its efficacy is limited in addressing the chronic, progressive, low-grade inflammatory, and the simple reduction of exogenous blood glucose can no longer meet the control of diabetes and its complications, nature of the disease. Consequently, there is an urgent need to identify safe and effective new therapeutic avenues. This letter corroborates the significance of intestinal flora in T2DM, as asserted by Li and Guo. It briefly outlines the role of intestinal flora in T2DM through insights from both animal experiments and clinical studies. Additionally, it discusses the potential clinical applications and challenges associated with targeting intestinal flora as therapeutic targets.
Publish Date	2024-04-11 08:04
Citation	Liu Y, Chang J, Bai LD. Intestinal flora: New perspective of type 2 diabetes. World J Clin Cases 2024; 12(11): 1996-1999
URL	https://www.wjgnet.com/2307-8960/full/v12/i11/1996.htm
DOI	https://dx.doi.org/10.12998/wjcc.v12.i11.1996

Full Article (PDF)	WJCC-12-1996-with-cover.pdf
Manuscript File	90120_Auto_Edited-YJP.docx
Answering Reviewers	90120-Answering reviewers.pdf
Audio Core Tip	90120-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	90120-Conflict-of-interest statement.pdf
Copyright License Agreement	90120-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	90120-Language certificate.pdf
Peer-review Report	90120-Peer-review(s).pdf
Scientific Misconduct Check	90120-Bing-Che XX-2.png
Scientific Editor Work List	90120-Scientific editor work list.pdf